Jump to content

Dextrorphan: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
P33M (talk | contribs)
P33M (talk | contribs)
Line 15: Line 15:
Dextrorphan is structurally similar to [[dextromethorphan]], and has an affinity for the same receptors in the [[central nervous system]], although with a slight difference in selectivity. While dextromethorphan is a weak non-competitive [[NMDA receptor antagonist]], dextrorphan is a more potent antagonist[http://jpet.aspetjournals.org/cgi/content/full/309/2/515?ijkey=73c6efcf7713b02798c855b5ce4d50f1aa22d299&keytype2=tf_ipsecsha#ABS].
Dextrorphan is structurally similar to [[dextromethorphan]], and has an affinity for the same receptors in the [[central nervous system]], although with a slight difference in selectivity. While dextromethorphan is a weak non-competitive [[NMDA receptor antagonist]], dextrorphan is a more potent antagonist[http://jpet.aspetjournals.org/cgi/content/full/309/2/515?ijkey=73c6efcf7713b02798c855b5ce4d50f1aa22d299&keytype2=tf_ipsecsha#ABS].


It should be noted, however, that due to its potency as an NMDA receptor antagonist, as well as the fact that it is produced as a by-product of DM metabolization in the body, DX is thought to be largely responsible for the psychological side-effects that occur at high doses of DM. These side-effects can include alteration of consciousness, or "cognitive dissociation", which are caracteristic of NMDA blockade and which have afforded DM its potential for abuse as a recreational drug.
It should be noted, however, that due to its potency as an NMDA receptor antagonist, as well as the fact that it is produced as a by-product of DM metabolization in the body, DX is thought to be largely responsible for the psychological side-effects that occur at high doses of DM. These side-effects can include alteration of consciousness, or "cognitive dissociation", which are characteristic of NMDA blockade and which have afforded DM its potential for abuse as a recreational drug.


==See also==
==See also==

Revision as of 06:59, 21 September 2007

Dextrorphan (DX) is a pharmacologically active metabolite of dextromethorphan (DM, DXM).

Dextrorphan
File:Dextrorphan 2D.gif
Identifiers
  • 17-methyl-9a,13a,14a-morphinan-3-ol
CAS Number
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.004.323 Edit this at Wikidata
Chemical and physical data
FormulaC17H23NO
Molar mass257.371 g/mol g·mol−1

Chemistry

It is the result of O-demethylation of the prodrug by several enzymatic systems, although it is chiefly a product of the Cytochrome P450 IID6 (CYP2D6) pathway.

Pharmacology

Dextrorphan is structurally similar to dextromethorphan, and has an affinity for the same receptors in the central nervous system, although with a slight difference in selectivity. While dextromethorphan is a weak non-competitive NMDA receptor antagonist, dextrorphan is a more potent antagonist[1].

It should be noted, however, that due to its potency as an NMDA receptor antagonist, as well as the fact that it is produced as a by-product of DM metabolization in the body, DX is thought to be largely responsible for the psychological side-effects that occur at high doses of DM. These side-effects can include alteration of consciousness, or "cognitive dissociation", which are characteristic of NMDA blockade and which have afforded DM its potential for abuse as a recreational drug.

See also